| Hepatitis B Virus |
1 |
1 |
| Immunization |
0 |
0.9 |
| COVID-19 Vaccine |
0 |
0.64 |
| Vaccines |
0 |
0.98 |
| Primary Care |
0 |
0.29 |
| Hepatitis B Vaccine |
0 |
0.99 |
| Addiction |
0 |
0.19 |
| Liver Disease |
0 |
0.17 |
| Liver |
0 |
0.16 |
| Hepatitis |
0 |
0.15 |
| Liver Failure |
0 |
0.14 |
| Opioids |
0 |
0.13 |
| Child |
0 |
0.12 |
| Chronic Hepatitis B Virus (HBV) |
0 |
0.12 |
| COVID-19 |
0 |
0.12 |
| Epidemic |
0 |
0.12 |
| Pandemic |
0 |
0.12 |
| Biliary Disease |
0 |
0.1 |
| Clinical Guidelines |
0 |
0.08 |
| Hepatitis C Virus |
0 |
0.08 |
| Outbreak |
0 |
0.08 |
| Overdose |
0 |
0.08 |
| Vaccines for Adult |
0 |
0.08 |
| Washington |
0 |
0.08 |
| Hepatocellular Carcinoma |
0 |
0.07 |
| Health Insurance |
0 |
0.06 |
| West Virginia |
0 |
0.06 |
| AIDS |
0 |
0.04 |
| Blood |
0 |
0.04 |
| Cancer |
0 |
0.04 |
| Cirrhosis |
0 |
0.04 |
| Clinician Health and Well-Being |
0 |
0.04 |
| Electronic Health Record (EHR) and Healthcare Technology |
0 |
0.04 |
| Fellowship |
0 |
0.04 |
| Hand |
0 |
0.04 |
| Health Equity |
0 |
0.04 |
| Health Policy |
0 |
0.04 |
| Insurance |
0 |
0.04 |
| Kentucky |
0 |
0.04 |
| Maine |
0 |
0.04 |
| Medical Innovations |
0 |
0.04 |
| Renal Disease |
0 |
0.04 |
| Social Determinants of Health |
0 |
0.04 |
| Stigma |
0 |
0.04 |
| Tennessee |
0 |
0.04 |
| Travel Medicine |
0 |
0.04 |
| Virginia |
0 |
0.04 |
| End-Stage Renal Disease |
0 |
0.03 |
| Revenue and Practice Management |
0 |
0.03 |
| Medical Life |
0 |
0.02 |